1. Home
  2. IGA vs STXS Comparison

IGA vs STXS Comparison

Compare IGA & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voya Global Advantage and Premium Opportunity Fund of Beneficial Interest

IGA

Voya Global Advantage and Premium Opportunity Fund of Beneficial Interest

N/A

Current Price

$9.94

Market Cap

162.0M

Sector

Finance

ML Signal

N/A

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

N/A

Current Price

$1.19

Market Cap

139.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IGA
STXS
Founded
2005
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
162.0M
139.3M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
IGA
STXS
Price
$9.94
$1.19
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $3.00
AVG Volume (30 Days)
70.9K
★ 449.0K
Earning Date
01-01-0001
08-11-2026
Dividend Yield
★ 8.93%
N/A
EPS Growth
N/A
★ 16.67
EPS
★ N/A
N/A
Revenue
N/A
★ $29,346,617.00
Revenue This Year
N/A
$6.04
Revenue Next Year
N/A
$33.01
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$9.21
$1.22
52 Week High
$10.77
$3.59

Technical Indicators

Market Signals
Indicator
IGA
STXS
Relative Strength Index (RSI) 27.02 37.01
Support Level $9.85 N/A
Resistance Level $9.93 $1.98
Average True Range (ATR) 0.20 0.06
MACD -0.09 -0.01
Stochastic Oscillator 1.12 9.39

Price Performance

Historical Comparison
IGA
STXS

About IGA Voya Global Advantage and Premium Opportunity Fund of Beneficial Interest

Voya Global Advantage and Premium Opportunity Fund is a United States-based diversified, closed-end management investment company. The fund has two investment objectives. Its primary objective is to provide a high level of income, while the secondary objective is to seek capital appreciation. To achieve these objectives, the fund invests at least 80% of its managed assets in a portfolio of common stocks from various countries around the world, including the United States. Additionally, it uses an integrated derivatives strategies.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: